focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.02
Bid: 54.90
Ask: 54.94
Change: 0.52 (0.95%)
Spread: 0.04 (0.073%)
Open: 54.52
High: 55.02
Low: 54.20
Prev. Close: 54.50
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subordinated Debt Exchange Offer Results

11 Mar 2020 11:29

RNS Number : 7841F
Lloyds Banking Group PLC
11 March 2020
 

 

11 March 2020

NOT FOR DISTRIBUTION TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED) ("U.S. PERSON") OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER, THE "UNITED STATES") OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

 

LLOYDS BANKING GROUP PLC (LEI: 549300PPXHEU2JF0AM85) ANNOUNCES THE RESULTS OF ITS INVITATION TO EXCHANGE €750,000,000 FIXED RATE STEP-UP SUBORDINATED NOTES DUE 2030 (XS0214965534) ISSUED BY HBOS PLC (THE "EXISTING NOTES") FOR NEW EURO DENOMINATED SUBORDINATED NOTES (THE "NEW NOTES") TO BE ISSUED BY LLOYDS BANKING GROUP PLC

Further to its announcement on 2 March 2020, Lloyds Banking Group plc (the "Offeror") is today announcing the results of its invitation to all Holders (subject to the Offer Restrictions set out in the Exchange Offer Memorandum referred to below) who are Eligible Persons to Offer to Exchange any and all of their outstanding Existing Notes for New Notes to be issued by the Offeror (the "Exchange Offer").

The Exchange Offer was made on the terms of and subject to the conditions contained in an exchange offer memorandum dated 2 March 2020 (the "Exchange Offer Memorandum"). Capitalised terms not otherwise defined in this announcement have the same meaning as assigned to them in the Exchange Offer Memorandum.

 

RESULTS OF THE EXCHANGE OFFER

The Minimum New Issue Size Condition has been satisfied.

The aggregate principal amount of the Existing Notes accepted for exchange by the Offeror is €309,088,000.

The aggregate principal amount of New Notes to be issued by the Offeror is €309,088,000.

 

All valid Offers to Exchange Existing Notes in the Exchange Offer have been accepted.

 

ISIN

Issuer

Maturity Date

Optional Redemption Date

Status

Aggregate Principal Amount of Existing Notes Accepted for Exchange by the Offeror

Amount Outstanding Following Exchange Settlement

XS0214965534

 HBOS plc

18 March 2030

18 March 2025

Subordinated

€309,088,000

€440,912,000

Certain Details of the Existing Notes

The Existing Notes set out in the table below shall be exchanged for New Notes as further described below.

 

Certain Details of the New Notes

The table below identifies certain key characteristics of the New Notes to be issued by the Offeror pursuant to the Exchange Offer.

 

ISIN

Issuer

Maturity Date

Optional Redemption Date

Status

Coupon (%)

Interest Payment Dates

New Issue Size

XS2138286229

Lloyds Banking Group plc

18 March 2030

18 March 2025

 Subordinated

As per the Existing Notes

€309,088,000

 

The New Notes will be in bearer form in denominations of €100,000 and integral multiples of €1,000 in excess thereof, up to and including €199,000, and will initially be issued in global form.

 

Applications are expected to be made to the Financial Conduct Authority (the "FCA") under Part VI of the Financial Services and Markets Act 2000, as amended, for the New Notes to be admitted to the Official List of the FCA and to the London Stock Exchange plc for the New Notes to be admitted to trading on the London Stock Exchange's regulated market. Such admission is expected to occur on the Settlement Date.

 

Further details of the New Notes are set out in the Exchange Offer Memorandum.

 

Holders whose Existing Notes Offered for Exchange have not been accepted, or who did not participate in the Exchange Offer, will not be eligible to receive New Notes in exchange for such Existing Notes, will not be entitled to receive the Cash Amount, and will continue to hold such Existing Notes subject to their terms and conditions.

 

Accrued Interest Amount and Cash Amount

Holders who validly Offered to Exchange their Existing Notes at or prior to the Expiration Time and whose Offers to Exchange have been accepted will receive New Notes in an amount equal to the aggregate principal amount of such Existing Notes accepted for exchange.

 

Each such Holder will also receive the Accrued Interest Amount and the Cash Amount in respect of their Existing Notes so accepted for exchange.

 

Settlement Date

The Settlement Date for the Exchange Offer, including (i) delivery of the New Notes in exchange for Existing Notes validly Offered for Exchange and accepted and (ii) payment of the Accrued Interest Amount and the Cash Amount, is expected to be on or around 16 March 2020.

 

This announcement contains inside information in relation to the Existing Notes and is disclosed in accordance with the Market Abuse Regulation (EU) 596/2014 ("MAR"). For the purposes of MAR, this announcement is made by Douglas Radcliffe, Group Investor Relations Director.

 

- END -

 

For further information:

 

Investor Relations

Douglas Radcliffe +44 (0) 20 7356 1571

Group Investor Relations Director

douglas.radcliffe@lloydsbanking.com

 

Corporate Affairs

Matt Smith +44 (0) 20 7356 3522

Head of Media Relations

matt.smith@lloydsbanking.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCJBMBTMTTBBTM
Date   Source Headline
6th Apr 20235:38 pmRNSTransaction in Own Shares
5th Apr 20235:35 pmRNSTransaction in Own Shares
4th Apr 20235:55 pmRNSTransaction in Own Shares
4th Apr 20237:00 amRNSIFRS 17 Transition Document Issued
3rd Apr 20235:46 pmRNSTransaction in Own Shares
31st Mar 20235:40 pmRNSTransaction in Own Shares
31st Mar 20232:32 pmRNSTotal Voting Rights
30th Mar 20235:30 pmRNSTransaction in Own Shares
29th Mar 20236:16 pmRNSTransaction in Own Shares
28th Mar 20235:17 pmRNSTransaction in Own Shares
28th Mar 20234:45 pmRNSTotal Voting Rights
27th Mar 20235:18 pmRNSTransaction in Own Shares
24th Mar 20235:38 pmRNSTransaction in Own Shares
24th Mar 20239:12 amRNSNotice of Redemption
23rd Mar 20235:33 pmRNSTransaction in Own Shares
23rd Mar 20232:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:27 pmRNSTransaction in Own Shares
22nd Mar 202311:25 amRNS2022 Annual Report and Accounts
21st Mar 20235:55 pmRNSNotice of AGM
21st Mar 20235:40 pmRNSTransaction in Own Shares
20th Mar 20235:26 pmRNSTransaction in Own Shares
17th Mar 20235:28 pmRNSTransaction in Own Shares
16th Mar 20235:47 pmRNSTransaction in Own Shares
15th Mar 20235:33 pmRNSTransaction in Own Shares
14th Mar 20235:20 pmRNSTransaction in Own Shares
13th Mar 20235:29 pmRNSTransaction in Own Shares
10th Mar 20235:58 pmRNSTransaction in Own Shares
10th Mar 20234:07 pmRNSDirector/PDMR Shareholding
9th Mar 20235:43 pmRNSTransaction in Own Shares
8th Mar 20236:06 pmRNSTransaction in Own Shares
8th Mar 20232:26 pmRNSDirector/PDMR Shareholding
7th Mar 20235:39 pmRNSTransaction in Own Shares
7th Mar 20233:08 pmRNS2022 Form 20F Filed
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
6th Mar 20235:52 pmRNSTransaction in Own Shares
3rd Mar 20235:41 pmRNSTransaction in Own Shares
2nd Mar 20235:37 pmRNSTransaction in Own Shares
2nd Mar 202312:04 pmRNSPublication of Final Terms
1st Mar 20235:26 pmRNSTransaction in Own Shares
28th Feb 20235:41 pmRNSTransaction in Own Shares
28th Feb 20233:37 pmRNSTotal Voting Rights
27th Feb 20235:26 pmRNSTransaction in Own Shares
27th Feb 20232:00 pmRNSDirector/PDMR Shareholding
24th Feb 20235:46 pmRNSTransaction in Own Shares
24th Feb 20235:03 pmRNS2022 Form 20F Filed
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.